Propose: Dry eye is a common disease among glaucoma patient undergoing on topical medication for lowering intraocular pressure. In this study we determine the prevalence and risk factors of dry eye among glaucoma patients. Methodology: We conducted a prospective cross-sectional study at Kilimanjaro Christian Medical Center (KCMC), Ophthalmology Department, over a period of 8 months, from October 2018 to June of 2019. Purposive sampling technique was used, and patients with POAG aged 18 years and above were consecutively selected. Socio-demographic and clinical data were collected. The main outcome variable was dry eye. The data were summarized using SPSS version 23 and analyzed using the STATA software version 13. Results: A total of 325 patients were enrolled into the study; 56.6% were male and 43.4% were female. The mean age was 66.1 years (SD11.7). We found that the prevalence of dry eye using OSDI questionnaire was 79.7%; among them evaporative dry eye was found in 36.9% and aqueous deficiency in 43.4%; 87.1% had abnormal TBUT; abnormal ocular surface staining was found in 64.3%; Schirmer test was abnormal in 43.4% and 36.9% had meibomian gland dysfunction. The severity of dry eyes among those using OSDI questionnaire is: mild 22.1%, moderate 16.0% and severe 61.9%. Factors such as use of two or more medication (AOR = 2.55, 95% CI: 1.89 - 3.36), 2 - 5 years of medication (AOR = 1.52, 95% CI: 1.35 - 1.88) were associated with dry eye in patients with glaucoma at KCMC. Conclusion: Dry eye is highly prevalent in glaucoma patients in our setting, and showed also the high prevalence of signs and symptoms. The use of timolol combined with other medication in our study was shown to be a strong predictor of having dry eye. To be exposed to two or more medication is strongly predictors of having dry eye.
References
[1]
Tham, Y.C., Li, X., Wong, T.Y., Quigley, H.A., Aung, T. and Cheng, C.Y. (2014) Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. A Systematic Review and Meta-Analysis. Ophthalmology, 121, 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013
[2]
Tf, S., Fasina, O., Ashaye, A., Bekibele, C. and Olawoye, O. (2015) Ocular Surface Disease among Glaucoma Patients in Ibadan, South-West Nigeria. Journal of Ophthalmology of Eastern Central and Southern Africa, 19, 34-38.
[3]
Craig, J.P., et al. (2017) TFOS DEWS II Report Executive Summary. The Ocular Surface, 15, 802-812. https://doi.org/10.1016/j.jtos.2017.08.003
[4]
Foulks, G.N. (2003) Cornea and External Disease. Ophthalmology Clinics of North America, 16, 44-58. https://doi.org/10.1016/S0896-1549(02)00109-8
[5]
Craig, J.P., et al. (2017) TFOS DEWS II Definition and Classification Report. Ocular Surface, 15, 276-283. https://doi.org/10.1016/j.jtos.2017.05.008
[6]
Stern, M.E., Schaumburg, C.S. and Pflugfelder, S.C. (2013) Dry Eye as a Mucosal Autoimmune Disease. International Reviews of Immunology, 32, 19-41. https://doi.org/10.3109/08830185.2012.748052
[7]
Osae, A.E., et al. (2017) Epidemiology of Dry Eye Disease in Africa: The Sparse Information, Gaps and Opportunities. Ocular Surface, 15, 159-168. https://doi.org/10.1016/j.jtos.2017.01.001
[8]
Messmer, E.M. (2015) The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease. Deutsches Ärzteblatt International, 112, 71-81. https://doi.org/10.3238/arztebl.2015.0071
[9]
Shanti, Y., Shehada, R., Bakkar, M.M. and Qaddumi, J. (2020) Prevalence and Associated Risk Factors of Dry Eye Disease in 16 Northern West Bank Towns in Palestine: A Cross-Sectional Study. BMC Ophthalmology, 20, 26. https://doi.org/10.1186/s12886-019-1290-z
[10]
Outcomes, M. (2019) Characteristics and Risk Factors Associated with Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmology, 138, 58-68. https://doi.org/10.1001/jamaophthalmol.2019.4815
[11]
Paulsen, A.J., et al. (2014) Dry Eye in the Beaver Dam Offspring Study: Prevalence, Risk Factors, and Health-Related Quality of Life. American Journal of Ophthalmology, 157, 799-806. https://doi.org/10.1016/j.ajo.2013.12.023
[12]
Charan, J. and Biswas, T. (2013) How to Calculate Sample Size for Different Study Designs in Medical Research? Indian Journal of Psychological Medicine, 35, 121. https://doi.org/10.4103/0253-7176.116232
[13]
Ruangvaravate, N., Prabhasawat, P., Vachirasakchai, V. and Tantimala, R. (2018) High Prevalence of Ocular Surface Disease among Glaucoma Patients in Thailand. Journal of Ocular Pharmacology and Therapeutics, 34, 387-394.
[14]
Fechtner, R.D., Godfrey, D.G., Budenz, D., Stewart, J.A., Stewart, W.C. and Jasek, M.C. (2010) Prevalence of Ocular Surface Complaints in Patients with Laucoma Using Topical Intraocular Pressure-Lowering Medications. Cornea, 29, 618-621. https://doi.org/10.1097/ICO.0b013e3181c325b2
[15]
Rossi, G.C.M., Pasinetti, G.M., Scudeller, L. and Bianchi, P.E. (2013) Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life. Journal of Ocular Pharmacology and Therapeutics, 29, 390-394. https://doi.org/10.1089/jop.2011.0159
[16]
Yee, R.W. (2007) The Effect of Drop Vehicle on the Efficacy and Side Effects of Topical Glaucoma Therapy: A Review. Current Opinion in Ophthalmology, 18, 134-139. https://doi.org/10.1097/ICU.0b013e328089f1c8
[17]
Camp, A., et al. (2015) Dry Eye Specific Quality of Life in Veterans Using Glaucoma Drops. Contact Lens & Anterior Eye, 38, 220-225. https://doi.org/10.1016/j.clae.2015.02.001
[18]
Bartlett, J.D. and Keith, M.S. (2015) Associations between Signs and Symptoms of Dry Eye Disease: A Systematic Review. Clinical Ophthalmology, 9, 1719-1730. https://doi.org/10.2147/OPTH.S89700
